🟢 HCW Biologics is trading 14% up in pre-market; catalyst remains unclear

HCW Biologics is trading at $1.41, up +13.98%, with the specific catalyst unclear.

• No new company-specific announcement was identified for October 19. The latest company release located, dated October 9, covered FDA guidance and preparation for an IND application targeted for the first half of 2027.
• The Nasdaq was up 1.25% pre-market, a possible broad-market tailwind, while the biotech sector was reported down 3.65%. The October 9 update predates this move.